|
Market Cap (5-Jun) $4,960,185 (1,007th) |
Close (30-Jun) $0.038 |
Volume (30-Jun) 1,963,571 |
Shortsold (11-May) 1 (0.00%) (717th) |
|
52w High $0.60 |
52w Low $0.083 |
P/E - |
EPS -0.84 |
CHM released this announcement to the ASX on 9 August 2021, 9:19. The announcement is not marked as price sensitive, and is 2 page(s) in length and 205.19kb in size.
You can view all announcements from CHM and see how they appear on a price chart on the announcements page.
At the date of this announcement, CHM was 0.386% short sold according to ASIC data. It was ranked the 307th most shorted stock on the ASX. It remains ranked 717th as of the latest reported data (11 May 2026).
| Other Recent Announcements from CHM | |
|---|---|
| Notice under section 708A | 29 June 2023, 15:34 |
| Application for quotation of securities - CHM | 29 June 2023, 15:29 |
| Results of Extraordinary General Meeting | 29 June 2023, 11:42 |
| Change of Director's Interest Notice - GM | 9 August 2021, 9:19 |
| Dr Yi Lin appointed to Cellular Immunotherapy SAB | 6 August 2021, 9:36 |
| Chimeric Therapeutics CDH17 Investor Webinar | 28 July 2021, 9:48 |
| Chimeric licenses novel solid tumor CAR T therapy from Penn | 28 July 2021, 8:21 |
You must be logged in to post a reply.
Chimeric Therapeutics Ltd 